Five start-ups shortlisted for Women’s Cancer Innovation award

Five femtech start-ups have been shortlisted for the Women’s Cancer Innovation award, sponsored by FINN Partners. 

FINN Partners is one of the fastest-growing, global marketing communications firms in the world. With deep expertise across sectors, FINN Partners delivers a full range of integrated marketing services relevant to key industry practice groups.

The shortlisted companies in the oncology space stood out among some truly excellent entries in one of the most competitive categories.

A category winner will be decided by the award judge and announced at a virtual ceremony on May 2.

AOA Dx is developing the next frontier in early-stage cancer detection for women through its pioneering work in glycolipids and proprietary biomarker technology. Its revolutionary tumour marker ganglioside platform, GlycoLocate, is paving the way for life-saving early cancer detection.

DeepLook Medical, a Connecticut-based software firm, focuses on visual enhancement technology to advance medical imaging. DL Precise is the first in a series of innovative products using the company’s unique shape-recognition software to delineate the details of tumour morphology – a key to better diagnosis and treatment of malignancy across the field of oncology.

10zyme aims to encourage more women to take control of their own health by improving the access to primary HPV testing, the leading cause of cervical cancer. The start-up is working on a unique self-testing option that will support the one in three who can’t attend cervical cancer screening in the UK.

OncoGenomX is a Swiss-based company on a mission to become the best treatment guidance software for breast cancer and to make durable metastasis prevention an option and a reality for all patients. Its first product, PredictionStar, represents a novel method for determining the correct cancer treatment regimen for permanent prevention of metastasis.

BIONIRS develops technologies that use light to improve society’s quality of life. The company is currently focusing on creating a medical imaging system for mammography in diffuse reflectance geometry using infrared light to improve early breast cancer diagnosis.